Project Grant R01CA299354
Award Date 8/1/26
Completion Date 7/31/31
Dollars Obligated $678K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Newark, NJ 07107, USA
Similar Awards
- Federal Grant Award Summary Rutgers The State University of New Jersey, Robert Wood Johnson School of Nursing received a $861,930 Project Grant from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research Program (CFDA 93.394), awarded August 7, 2025, with a completion date of July 31, 2028. The award funds development and testing of a dyadic digital skin cancer prevention intervention targeting adolescents and their parents. The intervention leverages smartphone...
- The National Cancer Institute awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $599,978 under the Cancer Cause and Prevention Research program (CFDA 93.393) on July 1, 2026. The award funds a five-year prospective cohort study examining the relationship between perceived social obligations and clinical and patient-reported outcomes in 315 patients with advanced, poor-prognosis cancer. The research tests the hypothesis that higher patient-reported...
- The National Cancer Institute awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $303,431 on August 13, 2026, under the Cancer Research Manpower program (CFDA 93.398) to implement breast cancer early detection measures in primary healthcare facilities in Botswana. The award funds a five-year implementation research project guided by the Integrative Systems Praxis for Implementation Research (INSPIRE) methodology. The project will conduct key informant...
- The National Cancer Institute awarded Rutgers, The State University of New Jersey, School of Nursing $239,352 on August 11, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop a sequencing-free PCR-based method for deep T-cell receptor profiling using sloppy molecular beacons in single-cell droplet digital PCR. The recipient will deliver a diagnostic technique that identifies T-cell receptor variable gene segment usage while preserving alpha-beta chain...
- The National Cancer Institute awarded the University of Connecticut $444,991 on May 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a randomized trial of a dissonance-based sun safety intervention targeting young adult tanners. The research will test whether a cognitive dissonance induction intervention can reduce indoor and outdoor tanning among adults ages 20–39. The intervention incentivizes participants who actively tan to develop anti-tanning...
- The National Cancer Institute awarded Rutgers, The State University of New Jersey, School of Nursing $654,688 on April 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a comprehensive retrospective analysis of the implementation of local flavored cigar restriction policies across the United States. The research will assess real-world policy implementation strategies, capitalize on natural experiments in municipal policy adoption, and identify which...
- The National Cancer Institute awarded a cooperative agreement to Rutgers The State University of New Jersey for $975,000 on March 21, 2026, under the Cancer Treatment Research program (CFDA 93.395). The award funds clinical trial support infrastructure and operations for the Rutgers Cancer Institute and RWJBarnabas Health System across multiple hospital sites within the health system. The award supports a centralized research administration model through the Office of Human Research Services,...
- The National Cancer Institute awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $516,808 under the Cancer Treatment Research program (CFDA 93.395) on June 1, 2026, to elucidate the mechanism of targeting methionine synthase (MTR) to enhance anti-tumor immunity in KRAS-driven lung cancer. The recipient will conduct research to understand how MTR targeting enhances immune responses in KRAS-driven non-small cell lung cancer (NSCLC), which exhibits...
- The National Cancer Institute awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $651,545 on September 1, 2026, under the Cancer Treatment Research program (CFDA 93.395) to investigate the meningeal lymphatic system as a pathogenic driver of chemotherapy-induced cognitive impairment in cancer survivors. The research targets chemobrain, a persistent cognitive dysfunction affecting pediatric and adult cancer survivors whose underlying mechanisms remain...
- The National Cancer Institute, a division of the Department of Health and Human Services, awarded $641,071 to Rutgers The State University of New Jersey (School of Nursing) on September 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct epidemiological research characterizing the role of air pollution in breast cancer prognosis and survivorship among Black women. The research leverages the Women's Circle of Health Follow-Up Study, a population-based cohort...